Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma

Published 2010 View Full Article

Authors

Keywords

Journal

CANCER SCIENCE

Volume 102, Issue 1, Pages 137-143

Publisher

Wiley

Online

2010-09-24

DOI

10.1111/j.1349-7006.2010.01756.x

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CANCER SCIENCE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Ask a Question. Answer a Question.